[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100582836":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":30,"centralContacts":35,"locations":45,"responsibleParty":302,"collaborators":40,"id":304,"slug":305,"hasResults":306,"nctId":307,"briefTitle":308,"officialTitle":309,"acronym":40,"eligibilityCriteria":310,"healthyVolunteers":306,"sex":311,"minAge":312,"maxAge":40,"enrollmentInfo":313,"targetDuration":40,"studyType":316,"phases":317,"briefSummary":319,"conditions":320,"keywords":322,"overallStatus":48,"whyStopped":40,"lastUpdateSubmitDate":328,"lastUpdatePostDateStruct":329,"startDateStruct":332,"completionDateStruct":334,"leadSponsor":336,"locationsCount":337},{"fullName":5,"class":6},"Wayshine Biopharm, Inc.","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Dose level A selected from Phase I study","EXPERIMENTAL","BID",[13],"Drug: WSD0922-FU Tablets, Dose level A",{"label":15,"type":10,"description":11,"interventionNames":16},"Dose level B selected from Phase I study",[17],"Drug: WSD0922-FU Tablets, Dose level B",[19,26],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":24},"DRUG","WSD0922-FU Tablets, Dose level A","Oral, 21 days in each cycle",[9],[25],"WSD0922",{"type":20,"name":27,"description":22,"armGroupLabels":28,"otherNames":29},"WSD0922-FU Tablets, Dose level B",[15],[25],[31],{"name":32,"affiliation":33,"role":34},"Adjei Alex A., PhD","The Cleveland Clinic","PRINCIPAL_INVESTIGATOR",[36,42],{"name":37,"role":38,"phone":39,"phoneExt":40,"email":41},"Carina Yu","CONTACT","951-547-4692",null,"ling.yu@wayshinebiopharm.com",{"name":43,"role":38,"phone":39,"phoneExt":40,"email":44},"Wei Zhong","wei.zhong@wayshinebiopharm.com",[46,65,79,93,107,121,135,149,163,179,193,207,217,231,247,261,274,288],{"facility":47,"status":48,"city":49,"state":50,"zip":51,"country":52,"countryCode":53,"cosmosGeoPoint":54,"geoPoint":59,"contacts":60},"FOMAT Oncology","RECRUITING","Oxnard","California","93030","United States","US",{"type":55,"coordinates":56},"Point",[57,58],-119.17705,34.1975,{"lat":58,"lon":57},[61],{"name":62,"role":38,"phone":63,"phoneExt":40,"email":64},"Principal Investigator","805-483-1185","nkhan@fomatmedical.com",{"facility":66,"status":48,"city":67,"state":68,"zip":69,"country":52,"countryCode":53,"cosmosGeoPoint":70,"geoPoint":74,"contacts":75},"Cleveland Clinic Weston Hospital","Weston","Florida","33331",{"type":55,"coordinates":71},[72,73],-80.39977,26.10037,{"lat":73,"lon":72},[76],{"name":62,"role":38,"phone":77,"phoneExt":40,"email":78},"866-293-7866","saravid@ccf.org",{"facility":80,"status":48,"city":81,"state":82,"zip":83,"country":52,"countryCode":53,"cosmosGeoPoint":84,"geoPoint":88,"contacts":89},"Karmanos Cancer Institute","Detroit","Michigan","48201",{"type":55,"coordinates":85},[86,87],-83.04575,42.33143,{"lat":87,"lon":86},[90],{"name":62,"role":38,"phone":91,"phoneExt":40,"email":92},"231-487-3390","upretyd@karmanos.org",{"facility":94,"status":48,"city":95,"state":96,"zip":97,"country":52,"countryCode":53,"cosmosGeoPoint":98,"geoPoint":102,"contacts":103},"Hackensack Meridian Health-Southern Ocean Medical Center","Manahawkin","New Jersey","08050",{"type":55,"coordinates":99},[100,101],-74.25875,39.6954,{"lat":101,"lon":100},[104],{"name":62,"role":38,"phone":105,"phoneExt":40,"email":106},"609-597-6011","Jatin.desani@hmhn.org",{"facility":108,"status":48,"city":109,"state":110,"zip":111,"country":52,"countryCode":53,"cosmosGeoPoint":112,"geoPoint":116,"contacts":117},"Cleveland Clinic","Cleveland","Ohio","44195",{"type":55,"coordinates":113},[114,115],-81.69541,41.4995,{"lat":115,"lon":114},[118],{"name":62,"role":38,"phone":119,"phoneExt":40,"email":120},"866-320-4573","ADJEIA2@ccf.org",{"facility":122,"status":48,"city":123,"state":124,"zip":125,"country":52,"countryCode":53,"cosmosGeoPoint":126,"geoPoint":130,"contacts":131},"UPMC Hillman Cancer Center","Pittsburgh","Pennsylvania","15235",{"type":55,"coordinates":127},[128,129],-79.99589,40.44062,{"lat":129,"lon":128},[132],{"name":62,"role":38,"phone":133,"phoneExt":40,"email":134},"412-755-3069","villaruzl@upmc.edu",{"facility":136,"status":48,"city":137,"state":138,"zip":139,"country":52,"countryCode":53,"cosmosGeoPoint":140,"geoPoint":144,"contacts":145},"TxO Central\u002FSouth, Texas Oncology -Central\u002FSouth Texas","Austin","Texas","78745",{"type":55,"coordinates":141},[142,143],-97.74306,30.26715,{"lat":143,"lon":142},[146],{"name":62,"role":38,"phone":147,"phoneExt":40,"email":148},"888-864-4226","james.uyeki@usoncology.com",{"facility":150,"status":48,"city":151,"state":152,"zip":153,"country":52,"countryCode":53,"cosmosGeoPoint":154,"geoPoint":158,"contacts":159},"Virginia Cancer Specialists","Fairfax","Virginia","22031",{"type":55,"coordinates":155},[156,157],-77.30637,38.84622,{"lat":157,"lon":156},[160],{"name":62,"role":38,"phone":161,"phoneExt":40,"email":162},"703-636-1473","Alexander.Spira@USOncology.com",{"facility":164,"status":48,"city":165,"state":166,"zip":167,"country":168,"countryCode":169,"cosmosGeoPoint":170,"geoPoint":174,"contacts":175},"Fujian Provincial Cancer Hospital","Fuzhou","Fujian","350014","China","CN",{"type":55,"coordinates":171},[172,173],119.30611,26.06139,{"lat":173,"lon":172},[176],{"name":62,"role":38,"phone":177,"phoneExt":40,"email":178},"86-0591-83660063","1609305255@qq.com",{"facility":180,"status":48,"city":181,"state":182,"zip":183,"country":168,"countryCode":169,"cosmosGeoPoint":184,"geoPoint":188,"contacts":189},"Wuhan Union Hospital","Wuhan","Hubei","430022",{"type":55,"coordinates":185},[186,187],114.26667,30.58333,{"lat":187,"lon":186},[190],{"name":62,"role":38,"phone":191,"phoneExt":40,"email":192},"86-27-85726300","xhzzdxr@126.com",{"facility":194,"status":48,"city":195,"state":196,"zip":197,"country":168,"countryCode":169,"cosmosGeoPoint":198,"geoPoint":202,"contacts":203},"Shanghai East hospital","Shanghai","Shanghai Municipality","200120",{"type":55,"coordinates":199},[200,201],121.45806,31.22222,{"lat":201,"lon":200},[204],{"name":62,"role":38,"phone":205,"phoneExt":40,"email":206},"86-21-38804518","caicunzhoudr@tongji.edu.cn",{"facility":208,"status":48,"city":195,"state":196,"zip":209,"country":168,"countryCode":169,"cosmosGeoPoint":210,"geoPoint":212,"contacts":213},"Shanghai Pulmonary Hospital","200433",{"type":55,"coordinates":211},[200,201],{"lat":201,"lon":200},[214],{"name":62,"role":38,"phone":215,"phoneExt":40,"email":216},"86-21-65115006","fywu@163.com",{"facility":218,"status":48,"city":219,"state":220,"zip":221,"country":168,"countryCode":169,"cosmosGeoPoint":222,"geoPoint":226,"contacts":227},"Tianjin Medical University Cancer Institute and Hospital","Tianjin","Tianjin Municipality","300202",{"type":55,"coordinates":223},[224,225],117.17667,39.14222,{"lat":225,"lon":224},[228],{"name":62,"role":38,"phone":229,"phoneExt":40,"email":230},"86-022-23353454","dingzhih72@163.com",{"facility":232,"status":48,"city":233,"state":234,"zip":235,"country":236,"countryCode":237,"cosmosGeoPoint":238,"geoPoint":242,"contacts":243},"Centre Hospitalier Universitaire (CHU) de Rennes - Hopital de Pontchaillou","Rennes","Ille-et-Vilaine","35000","France","FR",{"type":55,"coordinates":239},[240,241],-1.67431,48.11109,{"lat":241,"lon":240},[244],{"name":62,"role":38,"phone":245,"phoneExt":40,"email":246},"33-299-284321","herve.lena@chu-rennes.fr",{"facility":248,"status":48,"city":249,"state":250,"zip":251,"country":236,"countryCode":237,"cosmosGeoPoint":252,"geoPoint":256,"contacts":257},"Centre Hospitalier Universitaire CHU De Limoges","Limoges","New Aquitaine","87042",{"type":55,"coordinates":253},[254,255],1.24759,45.83362,{"lat":255,"lon":254},[258],{"name":62,"role":38,"phone":259,"phoneExt":40,"email":260},"33-555055555","Thomas.Egenod@chu-limoges.fr",{"facility":262,"status":48,"city":263,"state":250,"zip":264,"country":236,"countryCode":237,"cosmosGeoPoint":265,"geoPoint":269,"contacts":270},"CHU Bordeaux - Centre Francois Magendie","Pessac","33604",{"type":55,"coordinates":266},[267,268],-0.6324,44.80565,{"lat":268,"lon":267},[271],{"name":62,"role":38,"phone":272,"phoneExt":40,"email":273},"33-557656338","remi.veillon@chu-bordeaux.fr",{"facility":275,"status":48,"city":276,"state":277,"zip":278,"country":236,"countryCode":237,"cosmosGeoPoint":279,"geoPoint":283,"contacts":284},"Centre Francois Baclesse","Caen","Normandy","14000",{"type":55,"coordinates":280},[281,282],-0.35912,49.18585,{"lat":282,"lon":281},[285],{"name":62,"role":38,"phone":286,"phoneExt":40,"email":287},"33-231455050","h.curcio@baclesse.unicancer.fr",{"facility":289,"status":48,"city":290,"state":291,"zip":292,"country":236,"countryCode":237,"cosmosGeoPoint":293,"geoPoint":297,"contacts":298},"CHU Toulon - Hopital Sainte Musse","Toulon","Var","83100",{"type":55,"coordinates":294},[295,296],5.92836,43.12442,{"lat":296,"lon":295},[299],{"name":62,"role":38,"phone":300,"phoneExt":40,"email":301},"33-494145000","clarisse.audigier-valette@ch-toulon.fr",{"type":303,"investigatorFullName":40,"investigatorTitle":40,"investigatorAffiliation":40,"oldNameTitle":40,"oldOrganization":40},"SPONSOR","100582836","phase-2-a-study-to-assess-the-efficacy-of-wsd0922-fu-in-patients-with-c797s-advanced-non-small-cell-lung-cancer-100582836",false,"NCT06868485","A Study to Assess the Efficacy of WSD0922-FU in Patients With C797S+ Advanced Non-small Cell Lung Cancer","A Phase II, Open Label, Multicenter, Single Arm Study of WSD0922-FU for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer With First-Line Osimertinib Treatment and Harbor a C797S Mutation","Inclusion criteria:\n\n* Provision of signed and dated, written informed consent prior to any study-specific procedures, sampling and analyses.\n* Male or female aged ≥18 years old.\n* Histological or cytological confirmation diagnosis of NSCLC.\n* Locally advanced or metastatic NSCLC, not amenable to curative surgery or radiotherapy.\n* Evidence of radiological disease progression while on a previous continuous treatment with first-line Osimertinib treatment.\n* Documented EGFR mutation .\n* Eastern Cooperative Oncology Group (ECOG) 0-1 and a minimum life expectancy of 12 weeks.\n* At least one lesion, not previously irradiated and not chosen for biopsy during the study.\n* Females should have evidence of non-childbearing potential.\n\nExclusion criteria:\n\n* Any investigational agents or other anticancer drugs from a previous treatment regimen or clinical study within 14 days of the first dose of study treatment.\n* Any unresolved toxicities from prior therapy greater than CTCAE Grade 1.\n* Symptomatic brain complications that require urgent neurosurgical or medical intervention.\n* Any evidence of severe or uncontrolled systemic diseases.\n* Refractory nausea and vomiting, chronic gastrointestinal diseases, inability to swallow the formulated product or previous significant bowel resection.\n* Past medical history of ILD.\n* Inadequate bone marrow reserve or organ function as demonstrated.\n* Males and females of reproductive potential.\n* Known intracranial hemorrhage which is unrelated to tumor.\n* Seizures requiring a change in anti-epileptic medications.","ALL","18 Years",{"count":314,"type":315},40,"ESTIMATED","INTERVENTIONAL",[318],"PHASE2","This is a Phase II, Open Label, Multicenter, Single Arm Study of WSD0922-FU for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer whose Disease has Progressed with First-Line Osimertinib Treatment and whose Tumors harbor a C797S mutation within the Epidermal Growth Factor Receptor Gene.",[321],"Non Small Cell Lung Cancer",[323,324,325,326,327],"C797S","BM","WSD0922-FU","NSCLC","EGFR","2025-08-30",{"date":330,"type":331},"2025-09-08","ACTUAL",{"date":333,"type":331},"2025-08-18",{"date":335,"type":315},"2027-12-31",{"name":5,"class":6},18]